Enliven Therapeutics, Inc.
ELVN
$19.09
$0.351.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -9.66% | 23.82% | 10.76% | 12.43% | 9.72% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -28.28% | 57.10% | -0.37% | 7.02% | 12.54% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -99.46% | -- | -- | -- |
| Total Current Assets | -12.72% | 19.53% | 10.57% | 12.34% | 13.15% |
|
|
|||||
| Total Current Assets | -12.72% | 19.53% | 10.57% | 12.34% | 13.15% |
| Net Property, Plant & Equipment | 14.18% | -56.87% | -47.67% | -41.06% | -34.19% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 54.64% | 54.17% | 84.42% | 103.94% | 34.55% |
| Total Assets | -11.73% | 19.82% | 11.45% | 13.36% | 13.18% |
|
|
|||||
| Total Accounts Payable | -42.72% | 152.26% | -31.75% | -61.91% | -53.46% |
| Total Accrued Expenses | 2.52% | -2.01% | 58.88% | 115.07% | 191.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 44.84% | -- | -74.40% | -48.63% | -22.70% |
| Total Finance Division Other Current Liabilities | -98.60% | -98.03% | -41.30% | 1,271.53% | 1,258.39% |
| Total Other Current Liabilities | -98.60% | -98.03% | -41.30% | 1,271.53% | 1,258.39% |
| Total Current Liabilities | -44.18% | -38.54% | 40.96% | 141.66% | 128.76% |
|
|
|||||
| Total Current Liabilities | -44.18% | -38.54% | 40.96% | 141.66% | 128.76% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -98.33% | -93.31% |
| Total Liabilities | -43.05% | -38.70% | 38.51% | 132.58% | 118.91% |
|
|
|||||
| Common Stock & APIC | 13.21% | 38.24% | 28.08% | 27.65% | 27.24% |
| Retained Earnings | -53.52% | -57.64% | -63.09% | -72.46% | -81.57% |
| Treasury Stock & Other | 69.81% | -60.99% | 264.63% | -25.23% | -- |
| Total Common Equity | -9.26% | 26.00% | 10.18% | 9.30% | 9.02% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.26% | 26.00% | 10.18% | 9.30% | 9.02% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.26% | 26.00% | 10.18% | 9.30% | 9.02% |
|
|
|||||